| payload |
{"created_at":"2026-04-07T15:52:14.382 {"created_at":"2026-04-07T15:52:14.382912+00:00","dedupe_key":"signal_enriched:discovery_options_flow_delta:3dd8ebb5b1327aad","evidence_event_ids":["evt_1a9d11bafbf5"],"signal_type":"discovery_options_flow_delta","source":"discovery_ingestor","value":{"aggregator_url":"https://www.nasdaq.com/articles/company-news-apr-7-2026","as_of":"2026-04-07T15:52:14.382912+00:00","canonical_url":"https://www.nasdaq.com/articles/company-news-apr-7-2026","enrichment":{"aggregator_url":"https://www.nasdaq.com/articles/company-news-apr-7-2026","article_chars":2876,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_49bc9c8260a95f76","canonical_host":"nasdaq.com","canonical_is_aggregator":false,"canonical_url":"https://www.nasdaq.com/articles/company-news-apr-7-2026","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-07T16:22:14.659081+00:00","extraction_method":"heuristic","fetched_description":"Companies in The News Are: SLNO,NBIX,MU,AAPL,SNDK","fetched_title":"Company News for Apr 7, 2026 | Nasdaq","final_url":"https://www.nasdaq.com/articles/company-news-apr-7-2026","html_truncated":false,"paywall_likely":false,"publisher_domain":"nasdaq.com","publisher_resolution":"canonical_url","requested_url":"https://www.nasdaq.com/articles/company-news-apr-7-2026","source_event_id":"evt_1a9d11bafbf5","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"9b169e774a1ee550","kind":"options_flow","published_at":"2026-04-07T13:33:00+00:00","publisher_domain":"nasdaq.com","signal_understanding":{"analysis_basis":"article","claim_confidence":0.95,"dates_mentioned":["2026-04-07"],"entities":[{"asset_class":"equity","name":"Soleno Therapeutics, Inc.","relevance":"high","symbol":"SLNO","type":"company"},{"asset_class":"equity","name":"Neurocrine Biosciences, Inc.","relevance":"high","symbol":"NBIX","type":"company"},{"asset_class":"equity","name":"Micron Technology, Inc.","relevance":"high","symbol":"MU","type":"company"},{"asset_class":"equity","name":"Sandisk Corporation","relevance":"high","symbol":"SNDK","type":"company"},{"asset_class":"equity","name":"Apple Inc.","relevance":"high","symbol":"AAPL","type":"company"}],"event_type":"merger_acquisition","information_gaps":["No specific options flow data provided.","No details on days to expiry or size relative to open interest."],"key_facts":["SLNO shares surged 32.3% after acquisition announcement.","NBIX agreed to buy SLNO for $2.9 billion, or $53 per share in cash.","MU and SNDK shares rose on semiconductor rally."],"numeric_claims":[{"label":"SLNO share increase","value":"32.3%"},{"label":"acquisition price per share","value":"$53"},{"label":"acquisition total value","value":"$2.9 billion"}],"primary_claim":"SLNO shares increased by 32.3% following an acquisition announcement by NBIX.","relevance_score":0.9,"sentiment":"positive","source_quality":"high","summary":"Soleno Therapeutics, Inc. (SLNO) shares surged 32.3% after Neurocrine Biosciences, Inc. (NBIX) agreed to acquire it for $2.9 billion, while shares of Micron Technology, Inc. (MU) and Sandisk Corporation (SNDK) rose due to a broader semiconductor rally.","topics":["merger","acquisition","stock performance"]},"source":"Nasdaq Investing","source_domain":"nasdaq.com","summary":"Companies in The News Are: SLNO,NBIX,MU,AAPL,SNDK","tickers":[],"title":"Company News for Apr 7, 2026","url":"https://www.nasdaq.com/articles/company-news-apr-7-2026"}}... |